Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-005944
Filing Date
2017-01-27
Accepted
2017-01-27 17:01:39
Documents
2
Period of Report
2017-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2149
2 POA DOCUMENT poa.txt EX-24.3_697088 1880
  Complete submission text file 0001209191-17-005944.txt   5345
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Krogulski Kenneth (Reporting) CIK: 0001695580 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 17554517